Biological Dynamics Is Transforming Exosome Research and Advancing Liquid Biopsy with Its Proprietary ExoVerita Pro Platform

Biological Dynamics, a privately held San Diego-based company, is poised to revolutionize exosome/extracellular vesicle (EV) isolation and enrichment by addressing current research challenges and ultimately driving new liquid biopsy advancements. Biological Dynamics has developed an automated bench-top device, ExoVerita Pro, that uses alternating current electrokinetics (ACE) (see details below) to separate exosomes/EVs from other material in small samples of plasma (50-250 ┬ÁL). The platform offers a simple and automated workflow to enrich exosomes and EVs, bypassing many fundamental limitations of current isolation technologies. This technology is superior to the current exosome/EV separation methods such as ultracentrifugation and column purification in terms of purity and reproducibility and in process time, reducing it from days to hours. 

Login Or Register To Read Full Story